Mitochondrial-regulated Tregs: potential therapeutic targets for autoimmune diseases of the central nervous system

被引：1

作者：

Han, Aoya ^{[1
]}

Peng, Tingting ^{[1
]}

Xie, Yinyin ^{[1
]}

Zhang, Wanwan ^{[1
]}

Sun, Wenlin ^{[1
]}

Xie, Yi ^{[1
]}

Ma, Yunqing ^{[1
]}

Wang, Cui ^{[2
]}

Xie, Nanchang ^{[1
]}

机构：

[1] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou, Peoples R China

[2] Zhengzhou Univ, Dept Clin Lab, Affiliated Hosp 1, Zhengzhou, Peoples R China

来源：

FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷

基金：

中国国家自然科学基金;

关键词：

mitochondria; regulatory T cell; Foxp3; self-tolerance; central nervous system; autoimmune diseases; T-CELL DIFFERENTIATION; FOXP3; METABOLISM; HYPOXIA; DYSFUNCTION; HIF-1-ALPHA; ACTIVATION; INHIBITION; DEHYDROGENASE; INSTABILITY;

D O I：

10.3389/fimmu.2023.1301074

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Regulatory T cells (Tregs) can eliminate autoreactive lymphocytes, induce self-tolerance, and suppress the inflammatory response. Mitochondria, as the energy factories of cells, are essential for regulating the survival, differentiation, and function of Tregs. Studies have shown that patients with autoimmune diseases of the central nervous system, such as multiple sclerosis, neuromyelitis optica spectrum disorder, and autoimmune encephalitis, have aberrant Tregs and mitochondrial damage. However, the role of mitochondrial-regulated Tregs in autoimmune diseases of the central nervous system remains inconclusive. Therefore, this study reviews the mitochondrial regulation of Tregs in autoimmune diseases of the central nervous system and investigates the possible mitochondrial therapeutic targets.

引用

页数：9

共 50 条

[1] The role and potential therapeutic targets of astrocytes in central nervous system demyelinating diseases
Tan, Rui
Hong, Rui
Sui, Chunxiao
Yang, Dianxu
Tian, Hengli
Zhu, Tao
Yang, Yang
FRONTIERS IN CELLULAR NEUROSCIENCE, 2023, 17
[2] Prostaglandins in the Inflamed Central Nervous System: Potential Therapeutic Targets
Sheremeta, Chynna-Loren
Yarlagadda, Sai
Smythe, Mark L.
Noakes, Peter G.
CURRENT DRUG TARGETS, 2024, 25 (13) : 885 - 908
[3] The potential therapeutic role of statins in central nervous system autoimmune disorders
O. Stüve
S. Youssef
S. Dunn
A. J. Slavin
L. Steinman
S. S Zamvil
Cellular and Molecular Life Sciences CMLS, 2003, 60 : 2483 - 2491
[4] The potential therapeutic role of statins in central nervous system autoimmune disorders
Stüve, O
Youssef, S
Dunn, S
Slavin, AJ
Steinmann, L
Zamvil, SS
CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (11) : 2483 - 2491
[5] Biomarkers in autoimmune diseases of the central nervous system
Zhang, Yin-Xi
Wang, Hong-Hao
Guo, Shou-Gang
Wu, Long-Jun
Ding, Mei-Ping
FRONTIERS IN IMMUNOLOGY, 2023, 14
[6] Biomarkers in autoimmune diseases of the central nervous system
Zhang, Fenghe
Gao, Xue
Liu, Jia
Zhang, Chao
FRONTIERS IN IMMUNOLOGY, 2023, 14
[7] Autoimmune Diseases of the Central Nervous System in Childhood
Brenton, J. Nicholas
Banwell, Brenda L.
JOURNAL OF PEDIATRIC NEUROLOGY, 2018, 16 (03) : 139 - 140
[8] Therapeutic potential of small interfering RNA for central nervous system diseases
Lovett-Racke, AE
Cravens, PD
Gocke, AR
Racke, MK
Stüve, O
ARCHIVES OF NEUROLOGY, 2005, 62 (12) : 1810 - 1813
[9] Proinflammatory cytokines a potential targets for therapeutic intervention in central nervous system disorders
Bernardini, R.
Di Benedetto, G.
Cantarella, G.
JOURNAL OF MOLECULAR NEUROSCIENCE, 2013, 51 : S21 - S21
[10] Muscarinic Receptors: Their Roles in Disorders of the Central Nervous System and Potential as Therapeutic Targets
Scarr, Elizabeth
CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (05) : 369 - 379

← 1 2 3 4 5 →